CYTK
Cytokinetics, Incorporated
NASDAQ · Healthcare · Biotechnology · US
$72.72
−1.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 40.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -58.27x
- Price / sales
- 142.47x
- Price / cash flow
- -18.20x
Enterprise value
- Enterprise value
- $10.2B
- EV / sales
- 143.95x
- EV / EBITDA
- -12.48x
- EV / EBIT
- -14.50x
- Market cap
- $10.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026